Hennion & Walsh Asset Management, Inc. Jazz Pharmaceuticals PLC Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 37,802 shares of JAZZ stock, worth $4.17 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
37,802
Previous 35,894
5.32%
Holding current value
$4.17 Million
Previous $4.42 Million
6.18%
% of portfolio
0.22%
Previous 0.21%
Shares
17 transactions
Others Institutions Holding JAZZ
# of Institutions
601Shares Held
60.5MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$678 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$664 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$272 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$257 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$217 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.91B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...